XERS R&D Expenses

Xeris Biopharma Holdings Inc · R&D Expenses

XERS logo

XERS R&D Expenses

Latest reported$34.81M
XERS R&D Expenses ($10.24M → $34.81M)
High-resolution chart · PNG

XERS r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
31,165,000
25,560,000
22,341,000
20,966,000
25,160,000
20,921,000
60,438,000
40,654,000
20,166,000
10,238,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.